PEPTONIC medical AB Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

PEPTONIC medical AB (publ), a pharmaceutical company, develops oxytocin based products for the treatment of menopausal symptoms. Its product includes Vagitocin, a developmental pharmaceutical preparation which is in Phase IIb study for the treatment of vaginal atrophy.

Company Highlights
Year Founded

2009

icon-altEmployees

11

Location (HQ)

SWE

Since Last Funding

6 months

Monthly Website Visitors

1.9K

icon-altTotal Investment Amt

$4.7M

Last Funding Round

Post Ipo Equity

icon-altYoY Headcount Growth

-26.49%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Medical Equipment Manufacturing

Biotechnology

Pharmaceutical